Sainath Gaddam is a Cardiology physician. OpenAlex indexes 32 publications with 695 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
14111 King Rd Ste 320
Frisco, TX 750360810
Telephone
469-888-4890Provider last certified this registry record 7 May 2024.
Industry payments
23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20252 payments
- Novo Nordisk IncProgram year20252 payments
- Cleerly, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
80.2%Statin16.9%Atorvastatin Calcium45%Rosuvastatin Calcium41%Pravastatin Sodium14%Part D≥83 patientsBeta blocker15.1%Metoprolol Succinate57%Carvedilol29%Metoprolol Tartrate5%Atenolol4%Propranolol Hcl4%Part D<11 patients+ 16 more classes in this area
Blood & clotting
12.3%P2Y12 inhibitor5.6%Clopidogrel88%Brilinta12%Part D<11 patientsFactor Xa inhibitor5.5%Eliquis73%Xarelto27%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
6%Potassium supplement2.7%Potassium Chloride100%Part D≥33 patientsProton pump inhibitor1.4%Pantoprazole Sodium69%Omeprazole31%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- AML-1090: Palliative Care Utilization and Resource Impact Among Hospitalized Patients With Acute Myeloid Leukemia at End of Life: A National Analysis, 2018–2022
Clinical Lymphoma Myeloma & Leukemia
2025 - CLINICAL OUTCOMES FOR MEDTRONIC EVOLUT-R VERSUS CORE VALVE TRANSCATHETER AORTIC VALVE IMPLANTATION
Journal of the American College of Cardiology
2018 - EFFECT OF HOSPITAL VOLUME ON TRANSCATHETER MITRAL VALVE REPAIR (TMVR) OUTCOMES: A NATIONWIDE INPATIENT SAMPLE ANALYSIS
Journal of the American College of Cardiology
2018 - TEMPORAL TRENDS IN THE UTILIZATION OF MECHANICAL CARDIAC SUPPORT (MCS) IN TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR): A NATIONWIDE INPATIENT SAMPLE ANALYSIS
Journal of the American College of Cardiology
2018
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”